CCR5 was upregulated across all myeloid cells in response to IFN-α treatment and after LPS treatment in pMGL, in direct contrast to previous reports that LPS restricts infection via downregulation of CCR5 in MDMs (98). This evidence concerns the gene CCR5 and infection.